Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.
2.

Mirk/Dyrk1B in cancer.

Friedman E.

J Cell Biochem. 2007 Oct 1;102(2):274-9. Review.

PMID:
17583556
3.

Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity.

Becker W, Joost HG.

Prog Nucleic Acid Res Mol Biol. 1999;62:1-17. Review.

PMID:
9932450
4.

MAPKs as mediators of cell fate determination: an approach to neurodegenerative diseases.

Miloso M, Scuteri A, Foudah D, Tredici G.

Curr Med Chem. 2008;15(6):538-48. Review.

PMID:
18336268
5.
6.

[Protein kinase CK2 and cancer: further clues are accumulating].

Filhol O, Cochet C.

Bull Cancer. 2002 Mar;89(3):261-5. Review. French.

7.

Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer.

Boutros T, Chevet E, Metrakos P.

Pharmacol Rev. 2008 Sep;60(3):261-310. doi: 10.1124/pr.107.00106. Review.

8.

Nuclear trafficking of pro-apoptotic kinases in response to DNA damage.

Yoshida K.

Trends Mol Med. 2008 Jul;14(7):305-13. doi: 10.1016/j.molmed.2008.05.003. Review.

PMID:
18539531
9.

ERK1/2 MAP kinases in cell survival and apoptosis.

Lu Z, Xu S.

IUBMB Life. 2006 Nov;58(11):621-31. Review.

10.

Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy.

Maddika S, Ande SR, Panigrahi S, Paranjothy T, Weglarczyk K, Zuse A, Eshraghi M, Manda KD, Wiechec E, Los M.

Drug Resist Updat. 2007 Feb-Apr;10(1-2):13-29. Review.

PMID:
17303468
11.

Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance.

Brozovic A, Osmak M.

Cancer Lett. 2007 Jun 18;251(1):1-16. Review.

PMID:
17125914
12.

Protein kinase CK2 in health and disease: From birth to death: the role of protein kinase CK2 in the regulation of cell proliferation and survival.

St-Denis NA, Litchfield DW.

Cell Mol Life Sci. 2009 Jun;66(11-12):1817-29. doi: 10.1007/s00018-009-9150-2. Review.

PMID:
19387552
13.

Tyrosine kinase signalling in embryonic stem cells.

Annerén C.

Clin Sci (Lond). 2008 Jul;115(2):43-55. doi: 10.1042/CS20070388. Review.

PMID:
18547167
14.

Regulation and function of IKK and IKK-related kinases.

Häcker H, Karin M.

Sci STKE. 2006 Oct 17;2006(357):re13. Review.

PMID:
17047224
15.

The RSK family of kinases: emerging roles in cellular signalling.

Anjum R, Blenis J.

Nat Rev Mol Cell Biol. 2008 Oct;9(10):747-58. doi: 10.1038/nrm2509. Review.

PMID:
18813292
16.

MAPK signalling: ERK5 versus ERK1/2.

Nishimoto S, Nishida E.

EMBO Rep. 2006 Aug;7(8):782-6. Review.

17.

DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles.

Aranda S, Laguna A, de la Luna S.

FASEB J. 2011 Feb;25(2):449-62. doi: 10.1096/fj.10-165837. Review.

18.

Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control.

Becker W.

Cell Cycle. 2012 Sep 15;11(18):3389-94. doi: 10.4161/cc.21404. Review.

19.

Identification of selective inhibitors of cdc2-like kinases 1 and 4 (Clk1, Clk4).

Coombs TC, Tanega C, Shen M, Neuenswander B, Porubsky P, Wang JL, Misteli T, Auld DS, Schoenen F, Thomas CJ, Aubé J.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2012 Apr 16 [updated 2013 May 8].

20.

Recent progress in histochemistry and cell biology: the state of the art 2005.

Taatjes DJ, Roth J.

Histochem Cell Biol. 2005 Dec;124(6):547-74. Review.

PMID:
16283358
Items per page

Supplemental Content

Support Center